• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
    All News #Library

    Ultragenyx`s Crysvita (Burosumab- twza) Receives Supplemental Approval in US

    FDA

    Ultragenyx`s Mepsevii (vestronidase alfa—vjbk)) Receives Supplemental Approval in US

    FDA

    Ultragenyx`s Crysvita (Burosumab twza) Receives Supplemental Approval in US

    FDA

    Ultragenyx Germany GmbH`s Mepsevii (vestronidase alfa) Receives Approval in Europe

    EMA

    Ultragenyx Pharm`s Crysvita (Burosumab-twza) Receives Supplemental Approval In US

    FDA

    Ultragenyx`s Mepsevii (Vestronidase ALFA-VJBK) Receives Supplemental Approval In US

    FDA

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.